Clinical evidence for synergy between immunotherapy and radiotherapy (SITAR)

Previous preclinical and clinical trials have shown promising antitumour activity and toxicity profile when employing the ‘Synergy between Immunotherapy and Radiotherapy’ (SITAR) strategy. Approximately, one in seven radiation therapy studies currently recruiting is investigating SITAR. This article...

Descripción completa

Detalles Bibliográficos
Autores principales: Gill, Suki, Nowak, Anna K, Bowyer, Samantha, Endersby, Raelene, Ebert, Martin A, Cook, Alistair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
RADIATION ONCOLOGY
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543060/
https://www.ncbi.nlm.nih.gov/pubmed/35699321
http://dx.doi.org/10.1111/1754-9485.13441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543060/
https://www.ncbi.nlm.nih.gov/pubmed/35699321
http://dx.doi.org/10.1111/1754-9485.13441

Ejemplares similares